News
RSS Feed
Showing items 1 through 10 of 21 articles.
-
WVU Cancer Institute partners with GOG Foundation to offer more access to clinical trials
The WVU Cancer Institute has joined the Gynecology Oncology Group (GOG) Foundation network to offer a larger portfolio of clinical trials to its patients.
-
WVU Cancer Institute enrolls first patients in breast cancer vaccine trial
The WVU Cancer Institute has enrolled two of the first three patients in a national clinical trial for a novel breast cancer vaccine.
-
WVU Cancer Institute Recognizes Clinical Trials Awareness Month
Employees of WVU Medicine and the WVU Cancer Institute came together on Monday, May 20 to join organizations across the world in celebrating Clinical Trials Day on May 20. This day recognizes those who conduct clinical trials, raises awareness of clinical trials and clinical research, and is an opportunity to show gratitude for the work they do to improve public health.
-
WVU Cancer Institute participating in immunotherapy clinical trial
The WVU Cancer Institute is recruiting participants for an immunotherapy clinical trial for patients with metastatic melanoma or recurrent or metastatic head and neck squamous cell carcinoma.
-
WVU researchers pursue blood test for colorectal cancer
Researchers at the West Virginia University Cancer Institute are evaluating a first-of-its-kind blood test for detecting colorectal cancer. Their findings may help propel the test toward inclusion in the U.S. Preventive Services Task Force’s recommendations for colorectal cancer screening.
-
WVU oncologist researches new treatment for cervical and vaginal cancers
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few.
-
WVU oncologist researches new treatment for cervical and vaginal cancers
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.
-
WVU Cancer Institute participating in ovarian cancer clinical trial
The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat ovarian cancer.
-
WVU Cancer Institute participating in gynecologic cancer clinical trial
The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat uterine and vaginal cancer.
-
Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award
Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.
